SARS-CoV-2 & FluA/B Rapid Antigen Test
The SARS‑CoV‑2 & Flu A/B Rapid Antigen Test is a rapid chromatographic immunoassay for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens of SARS‑CoV‑2, Influenza virus A, and Influenza virus B in human nasopharyngeal swab samples. This test is intended as an aid in the differential diagnosis of SARS‑CoV‑2, Influenza virus A, and Influenza virus B infections in individuals suspected of respiratory viral infections consistent with COVID‑19 or Influenza by their healthcare provider within the first 6 days of symptom onset. This product is intended for professional use in laboratory and near‑patient testing environments. Not for self‑testing.